ADOCIA news, videos and press releases
For more news please use our advanced search feature.
ADOCIA - More news...
ADOCIA - More news...
- ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025
- ADOCIA Announces its Financial Calendar for 2025
- ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone® Lispro, Milestone Associated with a $10 Million Payment
- Number of Shares and Voting Rights of ADOCIA as of November 30th, 2024
- Number of Shares and Voting Rights of ADOCIA as of October 31st, 2024
- ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
- ADOCIA Announces the Availability of a Prospectus for its Capital Increase and Convertible Bond Issue
- ADOCIA Announces Q2 2023 Financial Results and a €10 Million Financing Operation
- ADOCIA confirms its eligibility for the PEA–PME
- Number of Shares and Voting Rights of ADOCIA as of June 30th, 2023
- ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing
- Number of Shares and Voting Rights of ADOCIA as of May 31st, 2023
- Listing of ADOCIA Shares Suspended
- Number of Shares and Voting Rights of ADOCIA as of April 30th, 2023
- ADOCIA Announces the Appointment of Olivier Soula as Chief Executive Officer
- ADOCIA Announces the Release of its Universal Registration Document for the Year 2022
- ADOCIA Reports Financial Results of First Quarter 2023 and Provides an Update on its Activities
- ADOCIA Announces Its Annual Shareholders’ Meeting to Be Held on May 11, 2023 in Paris
- Number of Shares and Voting Rights of ADOCIA as of March 31st, 2023
- Number of Shares and Voting Rights of ADOCIA as of February 28th, 2023
- ADOCIA Announces Its Annual Results for 2022 and Provides Corporate and Financial Update
- Number of Shares and Voting Rights of ADOCIA as of January 31st, 2023
- Adocia Publishes Its Letter to Shareholders
- ADOCIA Announces Half Year Report on Adocia’s Liquidity Agreement With Kepler Capital Markets
- Number of Shares and Voting Rights of ADOCIA as of December 31st, 2022
- ADOCIA Announces its Financial Calendar for 2023
- ADOCIA Announces the Successful Phase 1 Study for BioChaperone® Lispro with Partner Tonghua Dongbao
- ADOCIA Announces its Participation at Upcoming Investor Conferences in January 2023
- Number of shares and voting rights of ADOCIA as of November 30th, 2022
- Adocia Strengthens Its Cash Position with EUR 6 Million Through the Issuance of Convertible Bonds Subscribed by European Investors in Order to Accelerate the Development of Key Products
